Aviceda Therapeutics has hit a snag in its goal to deliver a new treatment for geographic atrophy (GA), an advanced form of dry age-related macular degeneration. The biotech’s lead asset, AVD-104, ...

The biggest stories of the day delivered to your inbox.

The Champions League trophy awaits Europe’s best side come the end of the season. / News Images/IMAGO The Champions League is done and dusted for the calendar year after another blockbuster helping of ...

President Trump is expected to announce that Israel and Hamas are moving to a second phase of his peace plan in early 2026, but there remains a host of challenges and unanswered questions for the ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Eli Lilly’s ...

The Pentagon has launched a new “official Command” phase of its investigation into whether Sen. Mark Kelly will be punished for his involvement in a video that reminded members of the military they ...

Nuclear energy company Commonwealth Fusion Systems (CFS) said it would collaborate with chipmaker NVIDIA and energy ...

Rezolute’s stock has plunged 87% after the company’s rare disease drug flunked the final clinical test ahead of a planned approval application. The company had been evaluating ersodetug as a treatment ...

High-speed imaging of charged droplet dynamics reveals a critical transition in the role of non-uniform AC electric fields on ...

President Donald Trump’s Gaza ceasefire plan is set to enter a new phase within weeks, but crucial pieces of the agreement remain undefined as Israel tightens its military grip on the battered enclave ...

Ohio State kicker Jayden Fielding has put together a statistically strong career. He’s made 80.4% of his field goals over three seasons and has missed just one extra point. But two kicks continue to ...